Promethos Capital »

Novartis shares owned by Promethos Capital

Quarter-by-quarter ownership of Novartis (NVS) shares owned by Promethos Capital from 13F filings

Historical chart of Promethos Capital investment in Novartis

Tip: Access up to 7 years of quarterly data

All positions including Novartis held by Promethos Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novartis by Promethos Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $16M 141k 115.02
2024-06-30 $15M 141k 106.32
2024-03-31 $11M 112k 96.73

More positions owned by Promethos Capital

Sap Se Equity (SAP)
Taiwan Semiconductor Sp Equity (TSM)
Novartis Equity (NVS)
Manulife Financial Corp Equity (MFC)
Icici Bank Equity (IBN)
Dr. Reddy S Laboratories Equity (RDY)
Cgi Equity (GIB)
Wipro Equity (WIT)
Apple Equity (AAPL)
Shinhan Financial Group Equity (SHG)
Microsoft Corp Equity (MSFT)
Canadian Natl Railway Equity (CNI)
Hsbc Holdings Equity (HSBC)
Nutrien Equity (NTR)
Kb Financial Group Equity (KB)

View all positions for Promethos Capital

Top funds holding Novartis

Dodge & Cox
PRIMECAP Management Company
Dimensional Fund Advisors
Morgan Stanley
Bank of America Corporation
Franklin Resources
Goldman Sachs Group
Henderson Group
Principal Financial Group
Renaissance Technologies
Cullen Capital Management
Wells Fargo & Company
Envestnet Asset Management
BlackRock
BlackRock

View all funds holding Novartis